Essential Plus System
Clinical Resource Portal — For Healthcare Professionals Only
Nutritional Support for
GLP-1 Transition &
Metabolic Health
The Essential Plus System is a dual-format medical nutrition program — shake powder and chewable bar — designed to preserve lean muscle, support gut health, and sustain metabolic outcomes during and after GLP-1 therapy.
Target Population Overview
15–25M
GLP-1 Off-Ramp (T1) · Primary Target
30–50M
Active GLP-1 Users (T2)
96M+
Metabolic Health Population (T3)
Section 01 — Clinical Evidence Summary
Triple-Action Sunflower Science
The Essential Plus System is built around a differentiated "triple-action" sunflower ingredient platform — a single botanical source delivering three clinically relevant mechanisms: high-quality protein, prebiotic arabinoxylan fiber, and chlorogenic acid.
Sunflower Protein
Lean Mass Preservation During Caloric Restriction
High leucine-content sunflower protein supports muscle protein synthesis during the hypocaloric state induced by GLP-1 therapy, addressing the critical challenge of lean mass loss — up to 39% of total weight lost — in GLP-1 users.
Three-source system: Sunflower + Pea + Nextida GC™ Collagen Peptides (Rousselot) · Target: 26g/serving
Nextida GC™ Collagen Peptides
GLP-1 Endogenous Potentiation
Rousselot's Nextida GC hydrolyzed collagen peptides have demonstrated capacity to stimulate endogenous GLP-1 secretion via L-cell activation (Grasset et al., 2024), providing a physiological bridge for patients transitioning off pharmacologic therapy.
Grasset E. et al. (2024) · Gut L-cell activation via collagen peptide fractions · Primary T1 mechanism
Arrabina® + PHGG / Sunfiber®
Prebiotic Fiber & GI Tolerance
Hydrolyzed arabinoxylan (Arrabina®) supports SCFA production and microbiome diversity. Combined with PHGG/Sunfiber® (3g), the system provides clinically validated prebiotic support with demonstrated GI tolerability — critical for the GLP-1 population.
PHGG selected over FOS for superior GI tolerability in hypersensitive gut populations · Total fiber: ~5–6g/serving
Chlorogenic Acid
Insulin Sensitivity & Glucose Modulation
Naturally occurring chlorogenic acid from sunflower supports postprandial glucose regulation through inhibition of hepatic glucose-6-phosphatase and promotion of insulin receptor sensitivity — mechanistically relevant to the metabolic health population.
Internal CGM self-testing (March 2026) shows favorable postprandial glucose response · Full clinical study planned
Sunflower Lecithin + Acacia Gum
Emulsification & Nutrient Delivery
Sunflower lecithin (1.5g) and acacia gum (1.2g) provide a phosphatidylcholine-rich emulsification system supporting fat-soluble micronutrient absorption — avoiding soy lecithin for allergy-sensitive patients.
Soy-free · Non-GMO · Optimized for the GI-sensitive GLP-1 population
Micronutrient Premix
GLP-1 Micronutrient Gap Coverage
GLP-1 users face documented micronutrient depletion due to reduced food volume. The bar delivers an expanded premix including Vitamin D3, K2 (MK-7), B1, Vitamin C, zinc bisglycinate, and L-5-MTHF folate — clinically prioritized deficiencies in this population.
Bar is primary micronutrient delivery vehicle · ~2g consolidated premix · Sodium target: 200–250mg/serving
| Ingredient | Primary Mechanism | Clinical Relevance | Tier Relevance |
|---|---|---|---|
| Nextida GC™ Collagen Peptides | Endogenous GLP-1 potentiation via L-cell activation | Metabolic continuity post-pharmacotherapy | T1 Off-Ramp |
| Sunflower Protein (26g) | Leucine-mediated mTOR activation / MPS | Lean mass preservation during hypocaloric state | T1 T2 |
| Arrabina® Arabinoxylan | SCFA production, microbiome modulation | Gut health; GLP-1–gut axis maintenance | T2 T3 |
| PHGG / Sunfiber® | Viscous fiber; gastric emptying modulation | Satiety support; GI tolerability | T1 T2 T3 |
| Chlorogenic Acid | Hepatic glucose-6-phosphatase inhibition | Postprandial glucose modulation | T3 Metabolic |
Section 02 — Patient Profiles
Who Are We Looking to Support?
Three representative patients. Three distinct clinical challenges. One system designed to address them all.
DM
T1 Off-Ramp
"I lost 47 pounds on semaglutide. I stopped four months ago and I've already regained eleven. I'm doing everything right — why is this happening?"
Diane's story is one you're hearing with increasing frequency. She was a model patient — consistent dosing, dietary compliance, regular follow-up. Her A1c dropped from 6.4 to 5.7. She felt better than she had in a decade. Then her insurer stopped covering the drug.
What happened next was physiologically predictable but felt like a personal failure to Diane. Endogenous GLP-1 secretion had been suppressed during pharmacotherapy. Her gut's natural satiety signaling had atrophied. Her appetite returned with a vengeance, and lean muscle she had lost during the hypocaloric phase meant her resting metabolic rate was now lower than it was before she started.
The clinical gap here is real and underserved. Diane needed a bridge: something that could support her gut's GLP-1 axis naturally while delivering the protein her muscle tissue desperately needed. The Essential Plus Shake — built around Nextida GC™ collagen peptides shown to stimulate endogenous GLP-1 via L-cell activation, paired with 26g of three-source protein — was formulated for exactly this moment.
At 12 weeks on the system, Diane's weight regain curve had flattened. Her RD noted improved satiety scores and she reported feeling "back in control" for the first time since discontinuation.
MR
T2 Active
"The medication is working — I'm down 34 pounds. But I feel weaker than before I started. My grip strength is down and I'm exhausted by 2pm."
Marcus's endocrinologist has every reason to be pleased: A1c down from 8.1 to 6.6, blood pressure normalizing, triglycerides improving. The GLP-1 therapy is doing what it's supposed to do. But Marcus doesn't feel like a success story — he feels diminished.
The culprit is well-documented but often under-addressed. GLP-1 receptor agonists reduce total caloric intake dramatically, and without deliberate nutritional intervention, a significant portion of weight lost — estimates range from 25–39% — comes from lean mass. At 61, Marcus has limited physiological reserve to spare.
His diet diary told the story plainly: he was averaging 55–65g of protein per day, well below the 1.2–1.6g/kg target for a patient in his situation. He was also showing early signs of B-vitamin depletion — common in GLP-1 users due to dramatically reduced food volume — and reporting intermittent GI discomfort that was undermining adherence.
The Essential Plus System addressed each layer of his deficiency. The shake's three-source protein system brought his daily intake to target without forcing volume he couldn't manage. The PHGG/Sunfiber® + acacia gum combination resolved his GI tolerability issues within two weeks. And the bar's expanded micronutrient premix — specifically designed around the GLP-1 depletion pattern — addressed his fatigue at its nutritional root.
SP
T3 Metabolic
"My doctor told me I'm prediabetic and need to make changes before it becomes diabetes. I'm trying, but I don't know where to start with food. Everything feels overwhelming."
Sandra is the most common patient in primary care and the one most likely to fall through the cracks. She doesn't qualify for GLP-1 therapy under current insurance criteria. She's motivated but overwhelmed. And she's running out of time: without meaningful intervention, 15–30% of prediabetic patients will progress to Type 2 diabetes within 5 years.
Her RD's assessment revealed a diet high in refined carbohydrates and low in both protein and fiber — a pattern that creates chronic postprandial glucose spikes and drives progressive insulin resistance. She was a candidate for structured meal replacement as part of a broader lifestyle intervention.
The Essential Plus System's T3 positioning targets exactly her metabolic profile. Chlorogenic acid from sunflower supports postprandial glucose modulation through inhibition of hepatic glucose-6-phosphatase. The prebiotic arabinoxylan and PHGG fiber system improves gut microbiome diversity — increasingly recognized as a key driver of insulin sensitivity. And the 26g protein system replaces a refined-carbohydrate meal with a high-satiety, low-glycemic alternative that supports sustainable weight management without pharmacotherapy.
Sandra's story matters beyond her individual case. The T3 population represents the largest addressable market — 96M+ Americans — and the one where nutritional intervention has its highest preventive ROI. Catching these patients before the GLP-1 threshold is reached is both clinically superior and economically rational.
Section 03 — Product Formulation
Essential Plus System — Dual Format
Launches as shake powder (hero SKU), followed by the chewable bar at +4–6 months. Both formats are soy-free, gluten-free, and formulated without HMB based on RD feedback.
Shake — Active Ingredients
Per ServingProtein System
Sunflower Protein Concentrate~18–20gPrimary protein
Pea Protein Isolate~4–5gBCAA complement
Nextida GC™ Collagen Peptides~3–4gGLP-1 potentiation
Prebiotic Fiber
Arrabina® Hydrolyzed Arabinoxylan~2–3gPrebiotic fiber
PHGG / Sunfiber®3gGI tolerability
Suspension System
Sunflower Lecithin1.5gEmulsification
Acacia Gum1.2gSuspension stability
Key Specifications
Total Protein26gTarget
Total Fiber~5–6gPrebiotic
Sodium200–250mgTarget
Launch FlavorsVanilla · MochaHero SKUs
Gluten-Free✓Certified
Soy-Free✓No soy lecithin
HMBExcludedPer RD feedback
Preliminary CGM Data
Internal CGM self-testing (March 2026) of the Vanilla shake showed a favorable postprandial glucose response. Full clinical validation is planned. Data available on request.
Bar — Active Ingredients
Per ~84g BarCo-Extruded Protein Crisps
Sunflower Protein (crisps)26gPrimary protein
Pea Protein (crisps)7gBCAA complement
Tapioca Starch (crisps)8gTexture/binding
Fat System
Cocoa Butter1.5gMouthfeel
High-Oleic Sunflower Oil1.5gOxidative stability
Functional Additives
Vegetable Glycerin3gMoisture / texture
Micronutrient Premix~2gExpanded vitamins/minerals
Micronutrient Premix Detail
Vitamin D3✓Bar-only delivery
Vitamin K2 (MK-7)✓D3 synergy
Vitamin B1 (Thiamine)✓GLP-1 deficiency gap
Vitamin C✓Collagen synthesis
Zinc Bisglycinate✓High bioavailability
L-5-MTHF Folate✓Active folate form
B-Complex✓Metabolic support
Launch Timeline
Shake LaunchPhase 1Hero SKU
Bar Launch+4–6 monthsPhase 2
Bar Total Weight~84gPer bar
Section 04 — Patient Use Guidance
GLP-1 Off-Ramp & Metabolic Health Protocol
The Essential Plus System addresses three distinct clinical populations. Understanding the tier framework helps clinicians identify the right patients and set appropriate expectations for outcomes.
T1
GLP-1 Off-Ramp
15–25M Americans · Primary TargetPatients discontinuing GLP-1 pharmacotherapy within 24 months
- Supports endogenous GLP-1 maintenance via Nextida GC collagen peptides
- Lean mass preservation through 26g three-source protein system
- Gut microbiome restoration following pharmacotherapy
- Addresses primary weight regain risk at off-ramp
- Ideal for obesity medicine, bariatric, and endocrinology referral
T2
Active GLP-1 Users
30–50M Americans · Secondary TargetPatients currently on semaglutide, tirzepatide, or related agents
- Protein adequacy in reduced-volume eating state
- Micronutrient repletion for documented GLP-1 depletion gaps
- GI tolerability — PHGG and acacia gum support gut comfort
- Muscle preservation during ongoing caloric restriction
- Adjunct to MNT — appropriate for RD clinical integration
T3
Metabolic Health
96M+ Americans · Expansion MarketPrediabetes, insulin resistance, metabolic syndrome
- Chlorogenic acid supports postprandial glucose modulation
- Prebiotic fiber system supports microbiome and metabolic health
- High-protein, low-glycemic format supports weight management
- Appropriate for preventive nutrition protocols
- Suitable for RD meal replacement programming
Recommended Clinical Integration Protocol
1
Patient Identification
Screen for GLP-1 discontinuation plan, active use with protein gap, or metabolic risk profile.
2
Tier Assignment
Match to T1 (off-ramp), T2 (active user), or T3 (metabolic health) based on clinical profile.
3
Initiate Shake
Begin with Essential Plus Shake (Phase 1 SKU). Once daily as meal replacement or protein supplement.
4
Add Bar at Phase 2
Introduce Essential Plus Bar at +4–6 months for expanded micronutrient coverage.
5
Monitor & Adjust
Reassess protein adequacy, GI tolerance, and weight trajectory at 4-week intervals.